ArticleCurrent oncology (Toronto, Ont.)2015
Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada.
Article in Current oncology (Toronto, Ont.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- A Scoping Review on Calibration Methods for Cancer Simulation Models.Medical decision making : an international journal of the Society for Medical Decision Making · 2025Article
- Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations.Medical decision making : an international journal of the Society for Medical Decision Making · 2025Article
- The projected health and economic impact of increased colorectal cancer screening participation among Canadians by income quintile.Canadian journal of public health = Revue canadienne de sante publique · 2024Article
- The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.Journal of medical screening · 2024Article
- The OncoSim-Breast Cancer Microsimulation Model.Current oncology (Toronto, Ont.) · 2022Article
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.Journal of medical screening · 2021Article
- Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns?Current oncology (Toronto, Ont.) · 2021Review
- Large-scale systematic analysis of exposure to multiple cancer risk factors and the associations between exposure patterns and cancer incidence.Scientific reports · 2021Article
- Cost-utility analysis of colonoscopy or faecal immunochemical test for population-based organised colorectal cancer screening.United European gastroenterology journal · 2019Article
- The OncoSim model: development and use for better decision-making in Canadian cancer control.Current oncology (Toronto, Ont.) · 2017Article
- Colorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities.World journal of gastrointestinal endoscopy · 2016Review
- The economic burden of cancers attributable to tobacco smoking, excess weight, alcohol use, and physical inactivity in Canada.Current oncology (Toronto, Ont.) · 2016Article
- Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.Canadian journal of gastroenterology & hepatology · 2016Article
- Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland.BMJ open gastroenterology · 2015Article
- The Population Health Model (POHEM): an overview of rationale, methods and applications.Population health metrics · 2015Article
- Canadian considerations on updating the age of initiation for colorectal cancer screening in individuals at average risk.Canadian journal of surgery. Journal canadien de chirurgieReview
- Shooting for the Moon: Can We Cut Cancer Mortality in Canada By 50% By 2050?Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSeveral screening methods for colorectal cancer (crc) are available, and some have been shown by randomized trials to be effective. In the present study, we used a well-developed population health simulation model to compare the risks and benefits of a variety of screening scenarios. Tests considered were the fecal occult blood test (fobt), the fecal immunochemical test (fit), flexible sigmoidoscopy, and colonoscopy. Outcomes considered included years of life gained, crc cases and deaths prevented, and direct health system costs.
methodsA natural history model of crc was implemented and calibrated to specified targets within the framework of the Cancer Risk Management Model (crmm) from the Canadian Partnership Against Cancer. The crmm-crc permits users to enter their own parameter values or to use program-specified base values. For each of 23 screening scenarios, we used the crmm-crc to run 10 million replicate simulations.
resultsUsing base parameter values and some user-specified values in the crmm-crc, and comparing our screening scenarios with no screening, all screening scenarios were found to reduce the incidence of and mortality from crc. The fobt was the least effective test; it was not associated with lower net cost. Colonoscopy screening was the most effective test; it had net costs comparable to those for several other strategies considered, but required more than 3 times the colonoscopy resources needed by other approaches. After colonoscopy, strategies based on the fit were predicted to be the most effective. In sensitivity analyses performed for the fobt and fit screening strategies, fobt parameter values associated with high-sensitivity formulations were associated with a substantial increase in test effectiveness. The fit was more cost-effective at the 50 ng/mL threshold than at the 100 ng/mL threshold.
conclusionsThe crmm-crc provides a sophisticated and flexible environment in which to evaluate crc control options. All screening scenarios considered in this study effectively reduced crc mortality, although sensitivity analyses demonstrated some uncertainty in the magnitude of the improvements. Where possible, local data should be used to reduce uncertainty in the parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.